Clinical Trial Update: TEIPP Immunotherapy in Patients With NSCLC [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates completion of Phase 1 and Phase 2 testing of TEIPP immunotherapy in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TEIPP immunotherapy

Snippet

Sponsor: Erasmus Medical Center | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED